ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma.
52W Range
16thpctl
Volume
0.41×avg
Market Cap
2.16BUSD
P/E Ratio
13.0TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
ADMA Biologics, Inc.
ADMANASDAQ Global Market·USD·Closed
ADMA Biologics, Inc.
ADMANASDAQ·USD·Closed
$9.34
−1.48%
$9.34
−$0.14 (1.48%)
52W Range
16thpctl
Volume
0.41×avg
Mkt Cap
2.16BUSD
P/E
13.0TTM
Div Yield
–ann
ADMA: ADMA Biologics, Inc. Stock Analysis | finqOS
